News|Articles|April 2, 2009

MHRA Cracks Down on Counterfeit Drugs, Seizes $500 Million Worth of Fake Meds

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) seized nearly half a million pounds worth of counterfeit medicines on Mar. 26, 2009 in Middlesbrough, England, according to a MHRA press release.

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) seized nearly half a million pounds worth of counterfeit medicines on Mar. 26, 2009 in Middlesbrough, England, according to a MHRA press release. The enforcement team arrested four Chinese nationals allegedly involved in the sale and supply of counterfeit drugs.

“Enquiries suggest that the counterfeit medicines originated from China,” said MHRA’ Head of Enforcement Mick Deats in the release. The seized drugs were for erectile dysfunction, anxiety, and weight loss.

The UK and European Commission have stepped up their attacks on counterfeiting after counterfeit drug seizures increased throughout the European Union by nearly fivefold in 2005 alone (see back story, Report from Europe). GS1 UK, an independent supply-chain standard development organization, completed the EU’s Pharma Traceability Pilot program just a few months ago as part of these efforts. The EU pilot tracked 15 drugs in an effort to stress track-and-trace technology and to decrease the potential for counterfeiting (see back story, GS1 UK Successfully Completes Traceability Pilot). Also on the EC’s agenda is legislation to implement tighter auditing controls of active ingredients.


Related to this article

Intravenous therapy; drip chamber in focus against a colorful background | Image Credit: ©Anna Jurkovska -stock.adobe.com
This article explores the historical use of silicone oil in the performance of primary drug product packaging; design of experiment test results for selection of the cleaning agent and CCPs; assessment of visible residue limits and Fourier-transform infrared spectroscopy surface analysis; and setting health-based exposure limits for silicone oil using a non-uniform distribution model, and a previously published permitted daily exposure.
Putting Sustainability to Work in Pharma
Silvia Forroova, director of Partnerships & Sustainability at CPHI, and founder of the CPHI Sustainability Collective, provides a preview of the new Sustainability Summit at CPHI Milan 2026.